Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL: Palbociclib + ET vs Capecitabine in HR+/HER2- MBC
NCT02028507Phase 3Completed
- Sponsor
- GEICAM
- Start
- Mar 2014
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by GEICAM. Started Mar 2014; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02028507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028507.